ETI: Impact of an Infusion Therapy Nursing Expert Service on Length of Stay and Clinical Results of Venous Access Devices

Sponsor

Basque Health Service (Other)

Overall Status

Completed

CT.gov ID

NCT01548365

Collaborator

KRONIKGUNE Cronicity Research Centre (Other)

Enrollment

Location

Arms

Duration (Months)

9.1

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether an infusion therapy nursing expert service is effective in decreasing hospital length of stay, improving the clinical results of venous access devices and increasing patient satisfaction with venous access.

Condition or Disease	Intervention/Treatment	Phase
Patients With Prolonged Intravenous Therapy	Other: Infusion therapy nursing expert service	N/A

Study Design

Study Type:

Interventional

Actual Enrollment :

82 participants

Allocation:

Randomized

Intervention Model:

Parallel Assignment

Masking:

Single (Outcomes Assessor)

Primary Purpose:

Health Services Research

Official Title:

Impact of an Infusion Therapy Nursing Expert Service on Length of Stay, Clinical Results of Venous Access Devices and Satisfaction on Patients With Long Intravenous Therapy Prescription.

Study Start Date :

Mar 1, 2012

Actual Primary Completion Date :

Sep 1, 2012

Actual Study Completion Date :

Dec 1, 2012

Arms and Interventions

Arm	Intervention/Treatment
No Intervention: Control Group routine care for the selection, placement and maintenance of venous access devices (VAD).
Experimental: Infusion Therapy Nursing Expert Patients in this group will receive the infusion therapy nursing expert (ITNE) service.	Other: Infusion therapy nursing expert service The ITNE will assess the patient and treatment characteristics and use an evidence based decision making algorithm for the selection of the most suitable VAD. If the VAD needed is a PICC or a midline ITNE will place it following hospital's protocols. If needed, ITNE will also educate and support patients and next of keens in the maintenance of the device at home. If other devices such as peripheral catheters, central venous catheters (jugular or subclavian) or venous subcutaneous reservoirs are the preferable VADs for patients and treatment conditions, ITNE will work together with health professionals in charge of patients to activate the usual procedures to place the according device.

Arm

Intervention/Treatment

No Intervention: Control Group

routine care for the selection, placement and maintenance of venous access devices (VAD).

Experimental: Infusion Therapy Nursing Expert

Patients in this group will receive the infusion therapy nursing expert (ITNE) service.

Other: Infusion therapy nursing expert service

The ITNE will assess the patient and treatment characteristics and use an evidence based decision making algorithm for the selection of the most suitable VAD. If the VAD needed is a PICC or a midline ITNE will place it following hospital's protocols. If needed, ITNE will also educate and support patients and next of keens in the maintenance of the device at home. If other devices such as peripheral catheters, central venous catheters (jugular or subclavian) or venous subcutaneous reservoirs are the preferable VADs for patients and treatment conditions, ITNE will work together with health professionals in charge of patients to activate the usual procedures to place the according device.

Outcome Measures

Primary Outcome Measures

Hospital Length of Stay [3 months]

Secondary Outcome Measures

Venous Access Devices reaching end of treatment [3 months]
Incidence of complications derived from VAD [3 months]
Patients receiving intravenous therapy at home [3 months]
Patient satisfaction with VAD [3 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Require an estimated long prescription of intravenous treatment. These treatments may be of fluid therapy, pharmacological, nutritional or hemotherapy.
Estimation of 7 days or more of continuous intravenous therapy.
Estimation of an intermittent intravenous therapy of less than a week, but on a monthly basis or less and a total estimated duration superior to 3 months.
Be patient at Araba University Hospital

Exclusion Criteria:

To have a central venous catheter indwelled
MRSA (Methicillin Resistant Staphylococcus Aureus)
Younger than 18 years old

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Araba University Hospital	Vitoria-Gasteiz	Araba	Spain	01009

Sponsors and Collaborators

Basque Health Service
KRONIKGUNE Cronicity Research Centre

Investigators

Principal Investigator: Lucia Garate, MsC, Basque Health Service

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Lucia Garate Echenique, Nursing Research Supervisor, Basque Health Service

ClinicalTrials.gov Identifier:

NCT01548365

Other Study ID Numbers:

ITNE01

First Posted:

Mar 8, 2012

Last Update Posted:

Sep 23, 2013

Last Verified:

Sep 1, 2013

Keywords provided by Lucia Garate Echenique, Nursing Research Supervisor, Basque Health Service

Nursing Services

Catheterization, Central Venous

Catheters Indwelling

Catheterization, Peripheral

Study Results

No Results Posted as of Sep 23, 2013